SCHEMBL7424628

SCHEMBL7424628

Cc1cc(Cl)nc2c(O)cccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.61
KDM4E B2RXH2 4/20 0.46
PARP1 P09874 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 2/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
KMT2A Q03164 3/20 0.44
OPRK1 P41145 1/20 0.44
SLC6A2 P23975 1/20 0.43
HTT P42858 1/20 0.43
MEN1 O00255 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
NQO2 P16083 1/20 0.42
METAP2 P50579 1/20 0.42
CRHR1 P34998 1/20 0.41
TNKS O95271 2/20 0.40
TNKS2 Q9H2K2 2/20 0.40
CYP3A4 P08684 1/20 0.40
HIF1A Q16665 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1577814 0.83 LMNA (0.67) LMNAKDM4EPARP1CYP2C19KMT2A
SCHEMBL2873413 0.81 KDM4E (0.62) KDM4EPARP1CYP1A2CYP2C19CYP2D6
SCHEMBL27294564 0.81 NQO2 (0.49) LMNAKDM4EPARP1CYP1A2CYP2C19
SCHEMBL4299350 0.81 KDM4E (0.62) KDM4EPARP1CYP1A2CYP2C19CYP2D6
SCHEMBL30587187 0.81 KDM4E (0.62) KDM4EPARP1CYP1A2CYP2C19CYP2D6
SCHEMBL31685132 0.81 NQO2 (0.49) LMNAKDM4EPARP1CYP1A2CYP2C19
SCHEMBL29966202 0.80 KDM4E (0.61) KDM4EPARP1CYP1A2CYP2C19CYP2D6
SCHEMBL4302340 0.80 KDM4E (0.61) KDM4EPARP1CYP1A2CYP2C19CYP2D6
SCHEMBL4298175 0.80 KDM4E (0.61) KDM4EPARP1CYP1A2CYP2C19CYP2D6
SCHEMBL27551420 0.80 KDM4E (0.61) KDM4EPARP1CYP1A2CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1071669-A1 BICYCLIC COMPOUNDS HAVING AN ANTI-THROMBITIC EFFECT Boehringer Ingelheim Pharma KG (DE) 2001-01-31 EP disclosed
WO-1999054313-A1 BICYCLIC COMPOUNDS HAVING AN ANTI-THROMBITIC EFFECT BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-10-28 WO disclosed